Metropolis Healthcare has reported strong financial growth for the fiscal year ended March 31, 2026. The Board of Directors has approved an interim dividend of INR 1 per equity share, with a record date of May 19, 2026. Additionally, the company announced a transition in its statutory leadership, with Deloitte Haskins & Sells Chartered Accountants LLP appointed as the new auditors, alongside a senior management transition involving Dr. Nilesh Shah.
Financial Performance Overview
For the quarter ended March 31, 2026, Metropolis Healthcare recorded a standalone revenue from operations of INR 35,203.12 lakhs, reflecting sustained business momentum. The company achieved a standalone profit for the year from continuing operations of INR 15,714.10 lakhs. On a consolidated basis, the year ended March 31, 2026, saw revenue from operations climb to INR 164,584.59 lakhs, with a profit for the year attributable to the owners of INR 19,001.74 lakhs.
Dividend Declaration
The Board has declared a 2nd Interim Dividend of INR 1 per equity share (face value of INR 2) for the 2025-26 financial year. Investors should note the record date for this dividend is Tuesday, May 19, 2026. Payment to eligible shareholders is expected within 30 days of the declaration.
Auditor Appointment and Senior Management Changes
Following the completion of the second term of the current statutory auditors, B S R & Co. LLP, the Board has recommended the appointment of Deloitte Haskins & Sells Chartered Accountants LLP. This appointment is for a period of five consecutive years, beginning from the conclusion of the 26th Annual General Meeting until the end of the 31st Annual General Meeting.
In other organizational news, Dr. Nilesh Shah will transition from his full-time role as President – Internal Assurance to an advisory position, effective May 14, 2026. Consequently, he will step down from his classification as a Senior Management Personnel effective at the close of business hours on May 13, 2026.
Source: BSE
